{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:36:02Z","timestamp":1793831762140,"version":"4.6.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.jpsychires.2019.08.009","type":"journal-article","created":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T16:38:04Z","timestamp":1565973484000},"page":"21-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Comparative efficacy and acceptability of first-line drugs for the acute treatment of generalized anxiety disorder in adults: A network meta-analysis"],"prefix":"10.1016","volume":"118","author":[{"given":"Hairong","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutao","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengjie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajuan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiancang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2019.08.009_bib1","doi-asserted-by":"crossref","first-page":"d1199","DOI":"10.1136\/bmj.d1199","article-title":"Efficacy of drug treatments for generalised anxiety disorder: systematic review and meta-analysis","volume":"342","author":"Baldwin","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jpsychires.2019.08.009_bib2","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.euroneuro.2012.07.012","article-title":"Vortioxetine (Lu AA21004) in generalized anxiety disorder: results of an 8-week, multinational, randomized, double-blind, placebo-controlled clinical trial","volume":"22","author":"Bidzan","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2019.08.009_bib3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jad.2016.11.011","article-title":"Effects of levomilnacipran ER on noradrenergic symptoms, anxiety symptoms, and functional impairment in adults with major depressive disorder: post hoc analysis of 5 clinical trials","volume":"210","author":"Blier","year":"2017","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2019.08.009_bib4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0005-7967(93)90075-6","article-title":"Predicting outcome after treatment for generalised anxiety disorder","volume":"31","author":"Butler","year":"1993","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.jpsychires.2019.08.009_bib5","first-page":"9S","article-title":"Clinical practice guidelines. Management of anxiety disorders","volume":"51","author":"Canadian Psychiatric Association","year":"2006","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2019.08.009_bib6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/jrsm.57","article-title":"Using network meta-analysis to evaluate the existence of small-study effects in a network of interventions","volume":"3","author":"Chaimani","year":"2012","journal-title":"Res. Synth. Methods"},{"key":"10.1016\/j.jpsychires.2019.08.009_bib7","first-page":"1","article-title":"Efficacy of vortioxetine in working patients with generalized anxiety disorder","author":"Christensen","year":"2017","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jpsychires.2019.08.009_bib8","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jpsychires.2019.08.009_bib9","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1016\/S0140-6736(16)30381-6","article-title":"Anxiety","volume":"388","author":"Craske","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jpsychires.2019.08.009_bib10","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1080\/14656566.2018.1472767","article-title":"Comparing the efficacy of benzodiazepines and serotonergic anti-depressants for adults with generalized anxiety disorder: a meta-analytic review","volume":"19","author":"Gomez","year":"2018","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.jpsychires.2019.08.009_bib11","article-title":"Functional recovery in major depressive disorder: focus on early optimized treatment","volume":"18","author":"Habert","year":"2016","journal-title":"Prim. Care. Comp. CNS. Disord."},{"key":"10.1016\/j.jpsychires.2019.08.009_bib12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jpsychires.2017.10.018","article-title":"Efficacy and tolerability of different doses of three new antidepressants for treating major depressive disorder: a PRISMA-compliant meta-analysis","volume":"96","author":"He","year":"2018","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2019.08.009_bib13","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/jrsm.1044","article-title":"Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies","volume":"3","author":"Higgins","year":"2012","journal-title":"Res. Synth. Methods"},{"issue":"Suppl. 1","key":"10.1016\/j.jpsychires.2019.08.009_bib14","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/1471-244X-14-S1-S1","article-title":"Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders","volume":"14","author":"Katzman","year":"2014","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.08.009_bib15","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1177\/070674371205701211","article-title":"Predicting treatment response in major depressive disorder: the impact of early symptomatic improvement","volume":"57","author":"Kudlow","year":"2012","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2019.08.009_bib16","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/da.22702","article-title":"Vortioxetine versus placebo in major depressive disorder comorbid with social anxiety disorder","volume":"34","author":"Liebowitz","year":"2017","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jpsychires.2019.08.009_bib17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/ijcp.12328","article-title":"A randomised, double-blind, placebo-controlled, duloxetine-referenced study of the efficacy and tolerability of vortioxetine in the acute treatment of adults with generalised anxiety disorder","volume":"68","author":"Mahableshwarkar","year":"2014","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.jpsychires.2019.08.009_bib18","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/hup.2371","article-title":"A randomized, double-blind, fixed-dose study comparing the efficacy and tolerability of vortioxetine 2.5 and 10 mg in acute treatment of adults with generalized anxiety disorder","volume":"29","author":"Mahableshwarkar","year":"2014","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2019.08.009_bib19","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.euroneuro.2012.07.011","article-title":"Vortioxetine (Lu AA21004) 5 mg in generalized anxiety disorder: results of an 8-week randomized, double-blind, placebo-controlled clinical trial in the United States","volume":"22","author":"Rothschild","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2019.08.009_bib20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.eurpsy.2012.02.003","article-title":"Treatment patterns and costs in patients with generalised anxiety disorder: one-year retrospective analysis of data from national registers in Sweden","volume":"28","author":"Sandelin","year":"2013","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.08.009_bib21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12991-018-0190-6","article-title":"An open-label, flexible dose adaptive study evaluating the efficacy of vortioxetine in subjects with panic disorder","volume":"17","author":"Shah","year":"2018","journal-title":"Ann. Gen. Psychiatr."},{"key":"10.1016\/j.jpsychires.2019.08.009_bib22","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0140-6736(18)31793-8","article-title":"Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis","volume":"393","author":"Slee","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jpsychires.2019.08.009_bib23","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.2174\/1389450118666171117131151","article-title":"Vortioxetine treatment for anxiety disorder: a meta-analysis study","volume":"19","author":"Yee","year":"2018","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.jpsychires.2019.08.009_bib24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ajp.2017.01.016","article-title":"Efficacy and tolerability of vilazodone for the acute treatment of generalized anxiety disorder: a meta-analysis","volume":"26","author":"Zareifopoulos","year":"2017","journal-title":"Asian. J. Psychiatr."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395619307927?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395619307927?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:12:17Z","timestamp":1758366737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395619307927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":24,"alternative-id":["S0022395619307927"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2019.08.009","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative efficacy and acceptability of first-line drugs for the acute treatment of generalized anxiety disorder in adults: A network meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2019.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}